phloretin has been researched along with daunorubicin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morris, ME; Zhang, S | 1 |
| Cao, X; Dai, Z; Fang, L; Gibbs, S; Huang, Y; Sadee, W; Sun, D; Wen, P; Zheng, X | 1 |
| Fu, WM; Hsieh, IS; Yang, RS | 1 |
3 other study(ies) available for phloretin and daunorubicin
| Article | Year |
|---|---|
Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport.
Topics: Adenosine Triphosphatases; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Biological Transport; Daunorubicin; Dihydropyridines; Doxorubicin; Drug Interactions; Flavonoids; Genistein; Humans; Phloretin; Photoaffinity Labels; Silymarin; Time Factors; Transfection; Tritium; Tumor Cells, Cultured | 2003 |
Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia.
Topics: Apoptosis; Cell Hypoxia; Cell Line, Tumor; Daunorubicin; Drug Resistance, Neoplasm; Drug Synergism; Glucose; Glucose Transport Proteins, Facilitative; Glucose Transporter Type 1; Glucose Transporter Type 3; Humans; Neoplasms; Phloretin | 2007 |
Osteopontin upregulates the expression of glucose transporters in osteosarcoma cells.
Topics: Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Daunorubicin; Etoposide; Fluorouracil; Glucose Transport Proteins, Facilitative; Glucose Transporter Type 1; Glucose Transporter Type 3; Humans; Integrin alphaVbeta3; Membrane Transport Modulators; Methotrexate; Osteopontin; Osteosarcoma; Phloretin; Up-Regulation | 2014 |